beth israel deaconess medical center a harvard medical school teaching hospital

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Program Overview

Our Goal

The goal of the Hematology/Oncology Fellowship at BIDMC to foster future leaders in the field who will devote their careers, in varying proportions, to clinical care, teaching, and clinical or basic research. The fellowship provides trainees with the opportunity to develop outstanding depth and expertise in clinical and research areas of their choice and is designed to meet the professional and educational goals of all of its fellows. Our fellows benefit from abundant opportunities for mentorship, additional training throughout Harvard, and collaboration with other services through multidisciplinary conferences.

Our Patients

The number of patients that we see has been growing progressively, and we care for a diverse array of patients with both common and more esoteric clinical disorders. There are currently more than 51,000 patient visits per year to our ambulatory hematology/oncology center.  Read more about the BIDMC Cancer Center, through which the Division of Hematology/Oncology provides most of its clinical services >>

Clinical and Research Hub

BIDMC is an exciting hub of research and development for new treatment strategies, in fields such as biologic therapies of cancer, hemostasis and thrombosis, and endothelial cell biology. Furthermore, there are also flourishing clinical research activities spanning the breadth of hematology and oncology, emphasizing diagnosis, management, and longitudinal follow-up of patients. Of special note are laboratory-based programs on hematopoiesis, signal transduction, and the biochemistry of coagulation factors as well as translational research programs in prostate cancer, melanoma, renal cancer, adoptive immunotherapy, and hypercoaguable states.

Many of our clinical programs are multidisciplinary, which facilitates active discussion and collaboration between specialties. They also function as disease site programs within BIDMC (e.g. breast cancer, cutaneous oncology, thoracic oncology, genitourinary oncology, GI oncology). As our clinical and research programs have grown, so too have our faculty and fellowship ranks. In keeping with these developments, we work together with the fellows to adjust the breadth of rotations in our clinical training program to provide an optimal balance between managing patients with diverse disorders and allowing time for reflection, reading, and scholarly work.

Program Structure

The three-year program is designed to ensure that fellows first establish a solid foundation of clinical knowledge and experience through multiple clinical conferences, formal teaching sessions, and continuity care of a diverse panel of patients. The second and third years focus on deepening fellows' understanding of clinical hematology/oncology and consultative service, and providing them with time and flexibility to devote to scholarly work. During the third year, time and support are also provided to help fellows secure positions of their choice upon graduation.

Read more about the structure of the program >>